Bliss GVS Pharma Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Bliss GVS Pharma has a total shareholder equity of ₹10.5B and total debt of ₹832.9M, which brings its debt-to-equity ratio to 7.9%. Its total assets and total liabilities are ₹12.8B and ₹2.3B respectively. Bliss GVS Pharma's EBIT is ₹1.2B making its interest coverage ratio -36.2. It has cash and short-term investments of ₹2.2B.
Wichtige Informationen
7.9%
Verhältnis von Schulden zu Eigenkapital
₹832.88m
Verschuldung
| Zinsdeckungsgrad | -36.2x |
| Bargeld | ₹2.20b |
| Eigenkapital | ₹10.48b |
| Gesamtverbindlichkeiten | ₹2.34b |
| Gesamtvermögen | ₹12.83b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 506197's short term assets (₹8.5B) exceed its short term liabilities (₹1.9B).
Langfristige Verbindlichkeiten: 506197's short term assets (₹8.5B) exceed its long term liabilities (₹418.8M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 506197 has more cash than its total debt.
Schulden abbauen: 506197's debt to equity ratio has reduced from 12.9% to 7.9% over the past 5 years.
Schuldendeckung: 506197's debt is well covered by operating cash flow (126.1%).
Zinsdeckung: 506197 earns more interest than it pays, so coverage of interest payments is not a concern.